Am J Transplant, Volume 18, Suppl 3 Archives - Page 167 of 211 - ATC Abstracts

2018 American Transplant Congress
Long-Term Outcome of Pediatric Kidney Transplantation: A Single-Center Experience over the past Three Decades in Japan
Y. Aoki,¹ H. Satoh,¹ Z. Matsui,¹ R. Hamada,² Y. Hamasaki,³ S. Shishido.³
¹Urology and Kidney Transplantation, Tokyo Metropolitan Children's Medical Center, Fuchu-shi, Tokyo, Japan; ²Nephrology, Tokyo Metropolitan Children's Medical Center, Fuchu-shi, Tokyo, Japan; ³Nephrology, Toho University Faculty of Medicine, Ota-ku, Tokyo, Japan.
Purpose: Kidney transplantation (KTx) is the preferred treatment for children with ESRD. Although the steady advances in immunosuppression have enabled control of early acute rejection…
2018 American Transplant Congress
Increasing Obesity Prevalence in the United States Pediatric End-Stage Renal Disease Population
B. Shelton,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. McWilliams,¹ D. Sawinski,² J. Locke.¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL; ²Medicine, University of Pennsylvania, Philadelphia, PA.
Background: Obesity prevalence among children in the United States (US) is high, but the rate of increase has slowed over time. Among pediatric end-stage renal…
2018 American Transplant Congress
Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence after Liver Transplant
N. Hendon,¹ D. Salerno,¹ C. Sammons,¹ K. Halazun.²
¹Pharmacy, NewYork-Presbyterian Hospital, New York, NY; ²Surgery, Weill Cornell Medical College, New York, NY.
Despite limited benefit to patients within Milan criteria on explant, mTORi are routinely utilized for prevention of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT).…
2018 American Transplant Congress
Chronic Rejection: Risk Factors, Clinical Presentation and Outcome in Pediatric Liver Transplant Recipients: A Single Center Experience
T. Miloh, A. Cheng, D. Schady, R. Himes, K. Mysore, K. Hosek, J. Goss.
Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Chronic rejection (CR) is the leading indication for long term graft loss. We discuss our centers' experience with CR diagnosis and management. Method: Electronic medical…
2018 American Transplant Congress
Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection
C. McDermott, K. Carsky, P. Ferrin, A. Gaines, D. Chernobylsky, M. Killackey, A. Paramesh, R. Zhang, J. Buell.
Tulane University School of Medicine, New Orleans, LA.
Purpose: Because AMR can be a risk factor for graft loss, the expense created by AMR treatment may be subject to scrutiny in patients who…
2018 American Transplant Congress
Measles and Varicella Vaccination Status and Evidence of Immunity during Solid Organ Pre-Transplantation Evaluation
H. Daniels, C. Saracusa, S. Worley, B. Gonzalez.
Pediatric Infectious Diseases, Cleveland Clinic, Cleveland, OH.
Background: Ensuring complete vaccination is important during a pre-transplant evaluation (PTE), especially for live viral vaccines which are generally contraindicated after transplant. After one dose…
2018 American Transplant Congress
Providing Transplant Candidates with Guidance about Differences in Acceptance Criteria across Programs
C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^4,7 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2
¹Department of Medicine, Hennepin County Medical Center (HCMC), University of Minnesota (UMN), Minneapolis, MN; ²Department of Epidemiology and Community Health, UMN, Minneapolis, MN; ³College of Design, UMN, Minneapolis, MN; ⁴Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN; ⁵Department of Surgery, UMN, Minneapolis, MN; ⁶Division of Gastroenterology, Hepatology, and Nutrition, UMN, Minneapolis, MN; ⁷Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA; ⁸Division of Hepatology, University of Washington, Seattle, WA.
The Scientific Registry of Transplant Recipients (SRTR) provides federally mandated program-specific reports (PSR) to the public. Candidate acceptance criteria vary widely across programs for many…
2018 American Transplant Congress
Decreased Expression of Pro-Carcinogenic Genes Following Tacrolimus to Sirolimus Conversion in Liver Transplant Recipients
M. Bhat,¹ E. Pasini,¹ C. Baciu,¹ S. Kurian,² J. Levitsky.³
¹Multi Organ Transplant Program, University Health Network, Toronto, Canada; ²Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; ³Division of Gastroenterology & Hepatology, Department of Medicine, Northwestern University, Chicago.
Long-term survival post-transplant is significantly impacted by malignancy. mTOR-inhibitors (mTORis) have anti-neoplastic properties and are associated with a decreased incidence of certain malignancies compared to…
2018 American Transplant Congress
AMD3100 (Plerixafor) as a Single-Dose Stem Cell Mobilizing Agent in Vascularized Composite Tissue Allograft (VCA) Transplantation in a Canine Model
B. Swearingen,^1,2 S. Graves,^2,3 R. Storb,^2,3 D. Mathes.^1,2
¹Surgery; Division of Plastic and Reconstructive Surgery, University of Colorado School of Medicine, Aurora, CO; ²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ³Medicine, University of Washington Medical Center, Seattle, WA.
PURPOSE:Vascularized Composite Allograft (VCA) transplantation is a clinical reality but limited by chronic immunosuppression and rejection. Current clinical tolerance protocols rely on recipient conditioning and…
2018 American Transplant Congress
Role of Calcium/Calmodulin Kinase IV on Podocyte Function in Transplant Glomerulopathy
R. Bhargava, K. Maeda, A. Ferreti, M. Pavlakis, G. Tsokos.
Beth Israel Deaconess Medical Center, Boston.
Background : Transplant glomerulopathy(TG) a histological manifestation of chronic antibody mediated rejection and a major cause of late allograft loss. It is well accepted that…